Zealand Pharma announced on October 7, 2026 that its investigational amylin analog petrelintide met the primary endpoint in the ZUPREME-2 Phase 2 trial in adults with overweight or obesity and…
The U.S. FDA approved pritelivir (Hovilpri) on October 9, 2026, for the treatment of mucocutaneous herpes simplex virus (HSV) lesions in immunocompromised adults who did not adequately respond to standard…
The U.S. Food and Drug Administration (FDA) approved pirtobrutinib (Jaypirca), Eli Lilly’s non-covalent BTK inhibitor, on October 2, 2026, for the first-line treatment of adults with chronic lymphocytic leukemia (CLL)…
FOR IMMEDIATE RELEASE — September 30, 2026 | Source: Acumen Research and Consulting Global Artificial Organs Market to Reach USD 63.31 Billion by 2035, Growing at 8.2% CAGR The global…
The U.S. Food and Drug Administration has approved Atebrioz (zilurgisertib), a once-daily oral therapy developed by Mirum Pharmaceuticals, for the treatment of fibrodysplasia ossificans progressiva in patients aged 12 years…
The U.S. Food and Drug Administration has granted Premarket Approval to the Juveena Hydrogel System, a device developed by Rejoni, Inc. to reduce the formation and recurrence of intrauterine adhesions…
Anthropic says Claude agents helped identify ART, a previously uncharacterized CRISPR-like repeat system in bacteriophages, after autonomously scanning 1.9 billion protein clusters, though the system's actual biological function remains unknown.
Anthropic and OpenEvidence are partnering to bring free, locally adapted clinical decision-support AI to doctors across roughly 100 low- and middle-income countries, building on pilot work in Rwanda and Botswana…
Pharming has reported positive Phase II results for leniolisib in rare PI3Kδ-linked primary immunodeficiencies, showing a 26.4% mean spleen volume reduction in a 13-patient trial, with a larger CVID trial…
Karnataka's FDA has cancelled 16 drug licences and suspended eight more, including a Pfizer C&F depot, after uncovering a counterfeit-medicine racket that relabeled low-cost drugs as expensive life-saving injectables worth…
